John (Jack) McLane

John (Jack) McLane has an extensive work experience in various roles within the pharmaceutical and biopharmaceutical industries. John (Jack) is currently serving as the Chief Scientific Officer at Catawba Research, LLC since June 2020. Prior to that, they worked as a Senior Clinical and Regulatory Consultant at MCLANE PHD LLC from July 2019.

From July 2014 to July 2019, McLane held the position of Vice President Clinical Development at Tolmar, where they oversaw clinical strategies and operations, made clinical medical decisions, managed non-clinical studies, and supervised pharmacovigilance activities. John (Jack) also had the responsibility of managing a clinical budget of over $25 million/year and coordinating with outsourced vendors.

McLane's earlier experiences include serving as the COO & Vice President Clinical and Regulatory Affairs at Clinquest, Inc. from 2009 to June 2014. In this role, they managed strategy, operations, and budget while directing a team of 25+ people. John (Jack) also directed clinical trials and provided regulatory reporting requirements.

Before that, McLane worked as the Vice President Pharmaceutical Development at Ariston Pharmaceuticals, Inc. From 2004 to 2008, they managed an annual operational budget of $14 million and directed Phase I and IIb clinical trials. McLane also provided scientific and regulatory input for raising funds from venture capitalists.

In addition, McLane held the position of Vice President Clinical and Regulatory Affairs at Catalyst Oncology from January 2004 to September 2004. John (Jack) played a key role in establishing the company, developing business strategies, and attracting start-up funds.

Furthermore, McLane served as the Vice President Clinical and Regulatory Affairs at Milkhaus Labs, Inc. from 2002 to 2004. John (Jack) managed staff and service providers, supervised the development of research, clinical, and regulatory departments, and organized outsourced activities.

At the beginning of their career, McLane worked at Hoffmann-La Roche as the Director of Strategic Planning from 1987 to 2002. In this role, they managed cross-functional teams, provided regulatory strategic leadership, and developed clinical, regulatory, and marketing strategies for various products.

Overall, McLane's work experience demonstrates their expertise in clinical development, regulatory affairs, strategic planning, and budget management within the pharmaceutical industry.

John (Jack) McLane has a strong educational background in the field of biology and dermatology. John (Jack) completed their post-doctoral research fellowship at Yale University School of Medicine, focusing on dermatology and cell biology. Prior to that, they obtained a Master of Science (M.S.) and Doctor of Philosophy (Ph.D.) degree in Biology from the University of Rhode Island. Their undergraduate studies were completed at the University of Bridgeport, where they graduated cum laude with a Bachelor of Science (B.S.) degree in Biology, specializing in cell/cellular and molecular biology.

Additionally, McLane holds a certification from The Medical & Pharmaceutical Advisory Council, although the specific details regarding when and where they obtained this certification are not provided.